Literature DB >> 11169468

Substance P receptor expression by inhibitory interneurons of the rat hippocampus: enhanced detection using improved immunocytochemical methods for the preservation and colocalization of GABA and other neuronal markers.

R S Sloviter1, L Ali-Akbarian, K D Horvath, K A Menkens.   

Abstract

Two unresolved issues regarding the identification and characterization of hippocampal interneurons were addressed in this study. One issue was the longstanding inability to detect gamma-aminobutyric acid (GABA) in the somata of several hippocampal interneuron subpopulations, which has prevented the unequivocal identification of all hippocampal interneurons as GABA neurons. The second issue was related to the identification of the hippocampal interneurons that constitutively express substance P (neurokinin-1) receptors (SPRs). The recent development of neurotoxins that specifically target SPR-expressing cells suggests that it may be possible to destroy hippocampal inhibitory interneurons selectively for experimental purposes. Although SPRs are apparently expressed in the hippocampus only by interneurons, colocalization studies have found that most interneurons of several subtypes and hippocampal subregions appear SPR-negative. Thus, the identities and locations of the inhibitory interneurons that are potential targets of an SPR-directed neurotoxin remain in doubt. Using newly developed methods designed to copreserve and colocalize GABA and polypeptide immunoreactivities with increased sensitivity, the authors report that virtually all hippocampal interneuron somata that are immunoreactive for parvalbumin (PV), calbindin, calretinin, somatostatin (SS), neuropeptide Y, cholecystokinin, and vasoactive intestinal peptide exhibited clearly detectable, somal, GABA-like immunoreactivity (LI). Hippocampal SPR-LI was detected only on the somata and dendrites of GABA-immunopositive interneurons. All glutamate receptor subunit 2-immunoreactive principal cells, including dentate granule cells, hilar mossy cells, and hippocampal pyramidal cells, were devoid of detectable SPR-LI, even after prolonged electrical stimulation of the perforant pathway that induced the expression of other neuronal proteins in principal cells. Thus, hippocampal interneurons of all subtypes and subregions were found to be SPR-immunoreactive, including the PV-positive interneurons of the dentate hilus and hippocampus, and the SS-positive cells of area CA1, both of which were previously reported to lack SPR-LI. Only minor proportions of hippocampal interneurons appeared clearly devoid of detectable SPR-LI. These results demonstrate for the first time that all identified interneuron subpopulations of the rat hippocampus are GABA-immunoreactive, and that many inhibitory interneurons of all subtypes in all subregions of the rat hippocampus express SPRs constitutively. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11169468

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  23 in total

1.  Differential effects of treadmill exercise in early and chronic diabetic stages on parvalbumin immunoreactivity in the hippocampus of a rat model of type 2 diabetes.

Authors:  In Koo Hwang; Sun Shin Yi; Ki-Yeon Yoo; Ok Kyu Park; Bingchun Yan; Wook Song; Moo-Ho Won; Yeo Sung Yoon; Je Kyung Seong
Journal:  Neurochem Res       Date:  2011-04-24       Impact factor: 3.996

2.  Neurochemical and electrophysiological characteristics of rat striatal neurons in primary culture.

Authors:  Torsten Falk; Shiling Zhang; Emilie L Erbe; Scott J Sherman
Journal:  J Comp Neurol       Date:  2006-01-10       Impact factor: 3.215

3.  Stereological analysis of GluR2-immunoreactive hilar neurons in the pilocarpine model of temporal lobe epilepsy: correlation of cell loss with mossy fiber sprouting.

Authors:  Yiqun Jiao; J Victor Nadler
Journal:  Exp Neurol       Date:  2007-03-30       Impact factor: 5.330

4.  Selective loss of dentate hilar interneurons contributes to reduced synaptic inhibition of granule cells in an electrical stimulation-based animal model of temporal lobe epilepsy.

Authors:  Chengsan Sun; Zakaria Mtchedlishvili; Edward H Bertram; Alev Erisir; Jaideep Kapur
Journal:  J Comp Neurol       Date:  2007-02-10       Impact factor: 3.215

5.  MDMA decreases glutamic acid decarboxylase (GAD) 67-immunoreactive neurons in the hippocampus and increases seizure susceptibility: Role for glutamate.

Authors:  Courtney L Huff; Rachel L Morano; James P Herman; Bryan K Yamamoto; Gary A Gudelsky
Journal:  Neurotoxicology       Date:  2016-10-20       Impact factor: 4.294

6.  Hypothyroid states mitigate the diabetes-induced reduction of calbindin D-28k, calretinin, and parvalbumin immunoreactivity in type 2 diabetic rats.

Authors:  Sung Min Nam; Yo Na Kim; Dae Young Yoo; Sun Shin Yi; Woosuk Kim; In Koo Hwang; Je Kyung Seong; Yeo Sung Yoon
Journal:  Neurochem Res       Date:  2011-10-30       Impact factor: 3.996

7.  Substance P induces plasticity and synaptic tagging/capture in rat hippocampal area CA2.

Authors:  Ananya Dasgupta; Nimmi Baby; Kumar Krishna; Muhammad Hakim; Yuk Peng Wong; Thomas Behnisch; Tuck Wah Soong; Sreedharan Sajikumar
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-25       Impact factor: 11.205

8.  Selective loss of hilar neurons and impairment of initial learning in rats after repeated administration of electroconvulsive shock seizures.

Authors:  Nikolai V Lukoyanov; Maria J Sá; M Dulce Madeira; Manuel M Paula-Barbosa
Journal:  Exp Brain Res       Date:  2003-10-14       Impact factor: 1.972

9.  Expression of tryptophan 2,3-dioxygenase in mature granule cells of the adult mouse dentate gyrus.

Authors:  Koji Ohira; Hideo Hagihara; Keiko Toyama; Keizo Takao; Masaaki Kanai; Hiroshi Funakoshi; Toshikazu Nakamura; Tsuyoshi Miyakawa
Journal:  Mol Brain       Date:  2010-09-05       Impact factor: 4.041

10.  Amygdalar GABAergic-rich neural grafts attenuate anxiety-like behavior in rats.

Authors:  Miles Gregory Cunningham; Caroline Martine Connor; William A Carlezon; Edward Meloni
Journal:  Behav Brain Res       Date:  2009-06-17       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.